248 related articles for article (PubMed ID: 1899432)
1. Flecainide acetate treatment of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation: dose-response studies. The Flecainide Supraventricular Tachycardia Study Group.
Pritchett EL; DaTorre SD; Platt ML; McCarville SE; Hougham AJ
J Am Coll Cardiol; 1991 Feb; 17(2):297-303. PubMed ID: 1899432
[TBL] [Abstract][Full Text] [Related]
2. Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group.
Hopson JR; Buxton AE; Rinkenberger RL; Nademanee K; Heilman JM; Kienzle MG
Am J Cardiol; 1996 Jan; 77(3):72A-82A. PubMed ID: 8607395
[TBL] [Abstract][Full Text] [Related]
3. Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group.
Chimienti M; Cullen MT; Casadei G
Eur Heart J; 1995 Dec; 16(12):1943-51. PubMed ID: 8682031
[TBL] [Abstract][Full Text] [Related]
4. Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy. A multicenter, double-blind, crossover study of flecainide and placebo with transtelephonic monitoring. Flecainide Supraventricular Tachycardia Study Group.
Anderson JL; Gilbert EM; Alpert BL; Henthorn RW; Waldo AL; Bhandari AK; Hawkinson RW; Pritchett EL
Circulation; 1989 Dec; 80(6):1557-70. PubMed ID: 2513143
[TBL] [Abstract][Full Text] [Related]
5. Correlation of symptoms with occurrence of paroxysmal supraventricular tachycardia or atrial fibrillation: a transtelephonic monitoring study. The Flecainide Supraventricular Tachycardia Study Group.
Bhandari AK; Anderson JL; Gilbert EM; Alpert BL; Henthorn RW; Waldo AL; Cullen MT; Hawkinson RW; Pritchett EL
Am Heart J; 1992 Aug; 124(2):381-6. PubMed ID: 1636582
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of the anti-arrhythmia effect of intravenous flecainide in supraventricular tachyarrhythmias].
Garre L; Alvarez A; Cianciulli T; Quiroga J; Califano J; Mautner B
Arch Inst Cardiol Mex; 1989; 59(3):241-4. PubMed ID: 2506843
[TBL] [Abstract][Full Text] [Related]
7. Flecainide acetate for paroxysmal supraventricular tachyarrhythmias. The Flecainide Supraventricular Tachycardia Study Group.
Anderson JL; Platt ML; Guarnieri T; Fox TL; Maser MJ; Pritchett EL
Am J Cardiol; 1994 Sep; 74(6):578-84. PubMed ID: 8074041
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of long-term oral flecainide acetate in patients with responsive supraventricular tachycardia.
Hellestrand KJ
Am J Cardiol; 1996 Jan; 77(3):83A-88A. PubMed ID: 8607396
[TBL] [Abstract][Full Text] [Related]
9. Intravenous flecainide acetate for the clinical management of paroxysmal tachycardias.
Nathan AW; Camm AJ; Bexton RS; Hellestrand KJ
Clin Cardiol; 1987 May; 10(5):317-22. PubMed ID: 3109795
[TBL] [Abstract][Full Text] [Related]
10. Long-term safety and efficacy of flecainide in the treatment of supraventricular tachyarrhythmias: the United States experience. The Flecainide Supraventricular Tachyarrhythmia Investigators.
Anderson JL
Am J Cardiol; 1992 Aug; 70(5):11A-17A; discussion 17A-18A. PubMed ID: 1509993
[TBL] [Abstract][Full Text] [Related]
11. Intravenous flecainide acetate for supraventricular tachycardias.
Hellestrand KJ
Am J Cardiol; 1988 Aug; 62(6):16D-22D. PubMed ID: 3136630
[TBL] [Abstract][Full Text] [Related]
12. Short- and long-term efficacy and safety of flecainide acetate for supraventricular arrhythmias.
Hohnloser SH; Zabel M
Am J Cardiol; 1992 Aug; 70(5):3A-9A; discussion 9A-10A. PubMed ID: 1387287
[TBL] [Abstract][Full Text] [Related]
13. Clinical trials of flecainide acetate in the management of supraventricular arrhythmias.
Camm AJ; Bashir Y
Cardiologia; 1990 Mar; 35(3):193-7. PubMed ID: 2123129
[No Abstract] [Full Text] [Related]
14. Comparison of the safety and efficacy of flecainide versus propafenone in hospital out-patients with symptomatic paroxysmal atrial fibrillation/flutter. The Flecainide AF French Study Group.
Aliot E; Denjoy I
Am J Cardiol; 1996 Jan; 77(3):66A-71A. PubMed ID: 8607394
[TBL] [Abstract][Full Text] [Related]
15. Flecainide acetate prevents recurrence of symptomatic paroxysmal supraventricular tachycardia. The Flecainide Supraventricular Tachycardia Study Group.
Henthorn RW; Waldo AL; Anderson JL; Gilbert EM; Alpert BL; Bhandari AK; Hawkinson RW; Pritchett EL
Circulation; 1991 Jan; 83(1):119-25. PubMed ID: 1898640
[TBL] [Abstract][Full Text] [Related]
16. Antiarrhythmic treatment with flecainide (Tambocor). Clinical experience from 107 patients.
Frandsen F; Pless P; Mickley H; Møller M
Acta Cardiol; 1990; 45(5):351-7. PubMed ID: 1704167
[TBL] [Abstract][Full Text] [Related]
17. A randomized comparison of flecainide versus verapamil in paroxysmal supraventricular tachycardia. The Flecainide Multicenter Investigators Group.
Dorian P; Naccarelli GV; Coumel P; Hohnloser SH; Maser MJ
Am J Cardiol; 1996 Jan; 77(3):89A-95A. PubMed ID: 8607397
[TBL] [Abstract][Full Text] [Related]
18. Flecainide for supraventricular tachyarrhythmias.
Med Lett Drugs Ther; 1992 Jul; 34(875):71-2. PubMed ID: 1630411
[No Abstract] [Full Text] [Related]
19. Use of flecainide acetate in the treatment of supraventricular tachyarrhythmias.
Marwick TH; Woodhouse SP
Am J Cardiol; 1988 Jul; 62(1):171. PubMed ID: 3132846
[No Abstract] [Full Text] [Related]
20. Antiarrhythmic effects of azimilide in paroxysmal supraventricular tachycardia: efficacy and dose-response.
Page RL; Connolly SJ; Wilkinson WE; Marcello SR; Schnell DJ; Pritchett EL;
Am Heart J; 2002 Apr; 143(4):643-9. PubMed ID: 11923801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
